Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.48 AUD 0.81% Market Closed
Market Cap: 135.8m AUD

Vita Life Sciences Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Vita Life Sciences Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Vita Life Sciences Ltd
ASX:VLS
Net Income (Common)
AU$9.3m
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
8%
Mayne Pharma Group Ltd
ASX:MYX
Net Income (Common)
-AU$93.8m
CAGR 3-Years
31%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Income (Common)
AU$149.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Income (Common)
-AU$86.4m
CAGR 3-Years
-87%
CAGR 5-Years
-39%
CAGR 10-Years
-56%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Net Income (Common)
-AU$64.3m
CAGR 3-Years
-39%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
Net Income (Common)
-AU$4.8m
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Vita Life Sciences Ltd
Glance View

Market Cap
138.7m AUD
Industry
Pharmaceuticals

Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.

VLS Intrinsic Value
2.72 AUD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Vita Life Sciences Ltd's Net Income (Common)?
Net Income (Common)
9.3m AUD

Based on the financial report for Jun 30, 2025, Vita Life Sciences Ltd's Net Income (Common) amounts to 9.3m AUD.

What is Vita Life Sciences Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
8%

Over the last year, the Net Income (Common) growth was -1%. The average annual Net Income (Common) growth rates for Vita Life Sciences Ltd have been 4% over the past three years , 13% over the past five years , and 8% over the past ten years .

Back to Top